Other groups have reported an upregulation of rRNA processing and ribosomal biogenesis in NPM1 mutated AML via the ribosomal protein S2 (RPS2), suggesting a possible target for therapeutic intervention (Feng et al., 2023). Here, NPM1 is linked to acute myeloid leukemia.